Prior to joining Sellers Dorsey, Nomair was a Senior Research Assistant at the Duke-Margolis Center for Health Policy in the Value-Based Payment and Biomedical Innovation and Regulatory Policy departments. He was engaged in multi-stakeholder interviews to develop post-market incentive strategies for the FDA and Biomedical Advanced Research and Development Authority. Additionally, Nomair interviewed state Medicaid organizations and managed care organizations to conduct a landscape analysis of value-based purchasing arrangements. Previously, Nomair worked at the Wake Forest School of Medicine as a Health Policy Analyst, where he researched the health effects of electronic cigarettes and vaping in adolescents and drafted legislative history reports on community drug prevention laws pertaining to e-cigs in North Carolina.